Phacilitate Leaders World

Features, Workshops & Networking Agenda

Loading

Towards commercialization – accomplish the challenges of autologous cell and gene therapies

24 Jan 2019
Jasmine
Briefings
Speakers
Amol Ketkar, VP, Cell and Gene Therapy Product Development - GSK
Anthony Davies, Founder & CEO - Dark Horse Consulting
Boro Dropulic, CSO & General Manager - Lentigen Technology, Inc. a Miltenyi Biotec company
Oliver Bartelsen, Global Head of Business Development and Industrial Services - Miltenyi Biotec
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK